Loading
institutionsInstitution
Atrium Health Wake Forest Baptist Comprehensive Cancer Center
North Carolina's third NCI comprehensive centre, a national research base for cancer control and survivorship and a pioneer of tumour organoids.
Also called: Wake Forest Baptist Comprehensive Cancer Center
Overview
NCI comprehensive since 1990, the Wake Forest Baptist centre is now part of Atrium Health, giving it reach across the Carolinas and Georgia. It hosts one of the NCI Community Oncology Research Program's research bases, running national trials on cancer-related cognitive impairment, survivorship and supportive care. Its radiation oncology group is known for brain metastasis radiosurgery, and the Wake Forest Institute for Regenerative Medicine builds patient tumour organoids and tumour-on-a-chip systems for drug testing. Director Boris Pasche studies TGF-beta signalling and colorectal cancer.
Location
Winston-Salem, NC, US
Type
cancer center · Wake Forest University
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
NCI designation
comprehensive
OnCo score
#127 · 35 points (0 Newsweek + 15 NCI + 20 from 10 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-17.
Matched to Wake Forest Baptist Comprehensive Cancer Center, including child institutions. 56 works · 438 citations · 77% open access · 14% clinical trials · 2% reviews.
Oncology works per year
122022
112023
142024
112025
82026
Most works
- Lance D. Miller6 works
- Ravi Kumar Paluri6 works
- Ronny A. Bell5 works
- Kathryn E. Weaver5 works
- Kunal C. Kadakia5 works
- Jai N. Patel4 works
- Heidi D. Klepin4 works
- Carla Strom4 works
- Ruben Mesa4 works
- John M. Salsman4 works
Most cited
- NCORP Research Base (cancer control)
- Brain metastasis radiosurgery
- Tumour organoids (WFIRM)
Similar pages
- CompanyKiyatec
Shares Functional (ex vivo) drug testing, Patient-derived organoids, Glioma & glioblastoma.
- IdeaA bone marrow niche on a chip to study human dormancy
Shares Functional (ex vivo) drug testing, Patient-derived organoids, Lab models that fail to predict what happens in patients.
- IdeaAutomated combination discovery: patient-sample screens feeding Bayesian platform trials
Shares Functional (ex vivo) drug testing, Patient-derived organoids, Lab models that fail to predict what happens in patients, Colorectal cancer.
- IdeaTest drugs on freshly cut slices of the patient's own tumour
Shares Functional (ex vivo) drug testing, Patient-derived organoids, Lab models that fail to predict what happens in patients.
- IdeaPet dogs with spontaneous cancer as a bridge before human trials
Shares Lab models that fail to predict what happens in patients, National Cancer Institute (NIH), Glioma & glioblastoma.
- Company2cureX
Shares Functional (ex vivo) drug testing, Patient-derived organoids.
- CompanyCure-First
Shares Functional (ex vivo) drug testing, Patient-derived organoids.
- IdeaZebrafish avatars for a drug answer within a week
Shares Functional (ex vivo) drug testing, Lab models that fail to predict what happens in patients, Colorectal cancer.